Company News
KIDNEY Clinical Trial Results: RenalGuard Therapy ® Prevents Acute Kidney Injury after Cardiac Surgery
December 7, 2020
Late-Breaking KIDNEY Clinical Trial Results: RenalGuard Therapy Prevents Acute Kidney Injury after Cardiac Surgery
November 7, 2019
RenalGuard’s Ability to Prevent Contrast-Induced Acute Kidney Injury in Vascular Surgery Showcased at LINC 2019
February 6, 2019
RenalGuard Solutions Announces Appointment of Dr. Howard R. Levin as Chief Medical Officer
May 15, 2018
RenalGuard’s Ability to Prevent Contrast-Induced Acute Kidney Injury to be Showcased at TCT 2017
October 19, 2017
Initial Clinical Results Show Feasibility and Safety of RenalGuard Use to Reduce Risk of Cardiac Surgery-Associated Acute Kidney Injury
October 12, 2017
Meta-Analysis Shows RenalGuard(R) Offers Dramatic Benefit for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Cardiovascular Interventions
September 13, 2017
Study Confirms RenalGuard(R) Efficacy for Dramatically Lowering Risk of Contrast-Induced Acute Kidney Injury
August 29, 2017
RenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive Officer
July 10, 2017
RenalGuard Solutions Appoints J. Alex Martin, former Coherex Medical President and CEO, as Chairman
June 15, 2017
Events
RenalGuard will be featured at the following conferences. If you are attending and would like to meet with us, please contact info@renalguard.com.
| Conference | Date | Location |
|---|